A study to investigate efficacy and safety of tozorakimab injections compared with placebo in adult participants with symptomatic chronic obstructive pulmonary disease (COPD) with a history of COPD exacerbations and elevated eosinophils

Trial Identifier: AZ-RU-00008
Sponsor: AstraZeneca
Start Date: March 2025
Primary Completion Date: April 2026
Study Completion Date: April 2026
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
RU Izhevsk, RU, 426061
RU Moscow, RU, 105554
RU Moscow, RU, 125284
RU Penza, RU, 440067
RU Perm, RU, 614000
RU St-Petersburg, RU, 193231
RU Ulyanovsk, RU, 432009